Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Extracorporeal shockwave therapy to improve upper limb function after stroke

Official title: Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke: Randomized Controlled Trial.

Run by Gulf Medical University · NCT07520032 · Data updated 2026-11-12

This trial will try extracorporeal shockwave therapy alongside rehabilitation to see if it reduces arm spasticity and improves hand and arm function in adults six months after their first stroke.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorGulf Medical University
Academic / other
Locations1 site (Ajman, Ajman Emirate)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedFebruary 28, 2027
Study endsMarch 30, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT07520032 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 25–65 years old who had their first stroke about six months ago, can follow verbal instructions, and have a Modified Ashworth Scale score between 1 and 4.

Probably not a fit

Patients with recurrent stroke, severe upper‑limb contractures or deformities, chronic arm pain, pacemakers, active infections, or cancer are either excluded or unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 25–65 who had a first stroke about six months earlier and have moderate upper‑limb spasticity (Modified Ashworth Scale 1–4) are enrolled. Participants receive extracorporeal shockwave therapy (ESWT) sessions in addition to standard rehabilitation including stretching, mobility, strengthening, and functional training, with treatments delivered at Gulf Medical University in Ajman. The trial measures changes in spasticity, upper‑limb function, and safety/tolerability over the treatment period. Key exclusions include recurrent stroke, severe contractures or deformities, chronic pain affecting the arm, pacemakers, active infections, and malignancy.

Why it matters

Potential benefit: If successful, the approach could reduce spasticity and improve arm and hand function, making everyday tasks easier for stroke survivors.

How similar studies have gone: Previous clinical reports and small trials suggest ESWT can reduce post‑stroke spasticity and is generally safe, but standardized dosing and long‑term functional benefit remain incompletely established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Diagnosed as 1st stroke incidence 6 months back
2. Both male and female
3. Age 25 to 65 years
4. the ability to follow verbal instructions
5. Modified Ashworth Scale score 1-4

Exclusion criteria:

1. Recurrent stroke.
2. Severe contractures or deformities of upper extremity.
3. Chronic pain affecting upper extremity function.
4. malignant tumor, pacemakers, infection

Where it's running

  • Gulf Medical University
    Ajman, Ajman Emirate, United Arab Emirates
    Recruiting

Study contacts

  • Principal investigator: Sharmila banu Ali, DPT/MPT — Thumbay Physical Therapy and Rehabilitation Hospital
  • Study coordinator: Sharmila banu Ali, DPT
  • Email: sharmieashak@gmail.com
  • Phone: 067031555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.